1st Circ. Charts Conservative Post-Actavis Course In Loestrin

Law360 | February.26.2016

Members of Orrick’s Antitrust & Competition team co-authored an article on a recent First Circuit decision concerning "reverse payment" settlements of Hatch-Waxman Act-related pharmaceutical patent infringement claims.